These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 32536008)
1. FBXO22, an epigenetic multiplayer coordinating senescence, hormone signaling, and metastasis. Johmura Y; Harris AS; Ohta T; Nakanishi M Cancer Sci; 2020 Aug; 111(8):2718-2725. PubMed ID: 32536008 [TBL] [Abstract][Full Text] [Related]
2. Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer. Johmura Y; Maeda I; Suzuki N; Wu W; Goda A; Morita M; Yamaguchi K; Yamamoto M; Nagasawa S; Kojima Y; Tsugawa K; Inoue N; Miyoshi Y; Osako T; Akiyama F; Maruyama R; Inoue JI; Furukawa Y; Ohta T; Nakanishi M J Clin Invest; 2018 Dec; 128(12):5603-5619. PubMed ID: 30418174 [TBL] [Abstract][Full Text] [Related]
3. SCF Bai J; Wu K; Cao MH; Yang Y; Pan Y; Liu H; He Y; Itahana Y; Huang L; Zheng JN; Pan ZQ Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11754-11763. PubMed ID: 31138683 [TBL] [Abstract][Full Text] [Related]
4. SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence. Johmura Y; Sun J; Kitagawa K; Nakanishi K; Kuno T; Naiki-Ito A; Sawada Y; Miyamoto T; Okabe A; Aburatani H; Li S; Miyoshi I; Takahashi S; Kitagawa M; Nakanishi M Nat Commun; 2016 Feb; 7():10574. PubMed ID: 26868148 [TBL] [Abstract][Full Text] [Related]
5. Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1. Lignitto L; LeBoeuf SE; Homer H; Jiang S; Askenazi M; Karakousi TR; Pass HI; Bhutkar AJ; Tsirigos A; Ueberheide B; Sayin VI; Papagiannakopoulos T; Pagano M Cell; 2019 Jul; 178(2):316-329.e18. PubMed ID: 31257023 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of FBXO22 inhibits melanoma cell migration, invasion and angiogenesis via the HIF-1α/VEGF pathway. Zheng Y; Chen H; Zhao Y; Zhang X; Liu J; Pan Y; Bai J; Zhang H Invest New Drugs; 2020 Feb; 38(1):20-28. PubMed ID: 30887251 [TBL] [Abstract][Full Text] [Related]
7. F-Box Protein FBXO22 Mediates Polyubiquitination and Degradation of CD147 to Reverse Cisplatin Resistance of Tumor Cells. Wu B; Liu ZY; Cui J; Yang XM; Jing L; Zhou Y; Chen ZN; Jiang JL Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117675 [TBL] [Abstract][Full Text] [Related]
8. FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis. Guo F; Liu J; Han X; Zhang X; Lin T; Wang Y; Bai J; Han J Int J Biol Sci; 2019; 15(3):647-656. PubMed ID: 30745851 [TBL] [Abstract][Full Text] [Related]
9. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21. Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376 [TBL] [Abstract][Full Text] [Related]
11. FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression. Sun R; Xie HY; Qian JX; Huang YN; Yang F; Zhang FL; Shao ZM; Li DQ Cancer Res; 2018 Sep; 78(18):5274-5286. PubMed ID: 29945959 [TBL] [Abstract][Full Text] [Related]
12. FBXO22 promotes osteosarcoma progression via regulation of FOXO1 for ubiquitination and degradation. Zhang H; Bai Y; Li J; Chen T; Shang G J Cell Mol Med; 2024 Aug; 28(16):e70021. PubMed ID: 39153212 [TBL] [Abstract][Full Text] [Related]
13. The ubiquitin E3 ligase FBXO22 degrades PD-L1 and sensitizes cancer cells to DNA damage. De S; Holvey-Bates EG; Mahen K; Willard B; Stark GR Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34795058 [TBL] [Abstract][Full Text] [Related]
14. FBXO22 protein is required for optimal synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist D-serine. Dikopoltsev E; Foltyn VN; Zehl M; Jensen ON; Mori H; Radzishevsky I; Wolosker H J Biol Chem; 2014 Dec; 289(49):33904-15. PubMed ID: 25336657 [TBL] [Abstract][Full Text] [Related]
15. Fbxo22 promotes cervical cancer progression via targeting p57 Lin M; Zhang J; Bouamar H; Wang Z; Sun LZ; Zhu X Cell Death Dis; 2022 Sep; 13(9):805. PubMed ID: 36127346 [TBL] [Abstract][Full Text] [Related]
16. F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression. Tian X; Dai S; Sun J; Jin G; Jiang S; Meng F; Li Y; Wu D; Jiang Y Oncotarget; 2015 Sep; 6(26):22767-75. PubMed ID: 26087183 [TBL] [Abstract][Full Text] [Related]
17. SCF(FBXO22) regulates histone H3 lysine 9 and 36 methylation levels by targeting histone demethylase KDM4A for ubiquitin-mediated proteasomal degradation. Tan MK; Lim HJ; Harper JW Mol Cell Biol; 2011 Sep; 31(18):3687-99. PubMed ID: 21768309 [TBL] [Abstract][Full Text] [Related]
18. Global identification of phospho-dependent SCF substrates reveals a FBXO22 phosphodegron and an ERK-FBXO22-BAG3 axis in tumorigenesis. Liu P; Cong X; Liao S; Jia X; Wang X; Dai W; Zhai L; Zhao L; Ji J; Ni D; Liu Z; Chen Y; Pan L; Liu W; Zhang J; Huang M; Liu B; Tan M Cell Death Differ; 2022 Jan; 29(1):1-13. PubMed ID: 34215846 [TBL] [Abstract][Full Text] [Related]
19. Emerging role of FBXO22 in carcinogenesis. Cheng J; Lin M; Chu M; Gong L; Bi Y; Zhao Y Cell Death Discov; 2020; 6():66. PubMed ID: 32793396 [TBL] [Abstract][Full Text] [Related]